Catalyst Wire Dossier Catalyst Wire Dossier

Risperdal Consta

risperidone long-acting injectable · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

71 regulatory and trial events tracked for Risperdal Consta, covering 2006-07-31 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone [Phase 4]

See pricing